DCM
AXNX

Diag Capital Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Diag Capital Management’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$702K Buy
+46,485
New +$692K 0.8% 33

Other funds holding AXNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Diag Capital Management's AXNX Position: Q4 2018 in Review

Diag Capital Management opened a new position in Axonics, Inc. Common Stock (AXNX) in Q4 2018: 46,485 shares worth $702K. The stake represents 0.8% of the portfolio and ranks #33 among its holdings.

39 funds tracked by Wall St. Rank hold AXNX as of Q4 2018.

  • Diag Capital Management held 46,485 shares of Axonics, Inc. Common Stock worth $702K as of Q4 2018.
  • Axonics, Inc. Common Stock was a new Diag Capital Management position in Q4 2018.
  • Axonics, Inc. Common Stock made up 0.8% of Diag Capital Management's portfolio in Q4 2018, its #33 holding.
  • 39 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2018.

Based on Diag Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.